Showing results (1251-1260 of 1,267) with videos related to

Sort By:
Pageof 127
JAMA|September 22, 2011
Prediction of erectile function following treatment for prostate cancerMehrdad Alemozaffar, Meredith M Regan, Matthew R Cooperberg, et al.
Journal of Thrombosis and Haemostasis : JTH|April 13, 2024
Three-year outcomes of valoctocogene roxaparvovec gene therapy for hemophilia ABella Madan, Margareth C Ozelo, Priyanka Raheja, et al.
European Urology|October 8, 2024
Impact of Gene Expression Classifier Testing on Adjuvant Treatment Following Radical Prostatectomy: The G-MINOR Prospective Randomized Cluster-crossover TrialTodd M Morgan, Stephanie Daignault-Newton, Daniel E Spratt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2023
Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitorsK D Lewis, K Peris, A Sekulic, et al.
Journal of Thrombosis and Haemostasis : JTH|September 7, 2023
Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1Brian O'Mahony, Amy L Dunn, Andrew D Leavitt, et al.
Nature Microbiology|March 30, 2026
Conserved pathway for homarine catabolism in environmental bacteriaFrank X Ferrer-González, Katherine R Heal, Joshua S Sacks, et al.
The New England Journal of Medicine|February 22, 2023
Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia AJohnny Mahlangu, Radoslaw Kaczmarek, Annette von Drygalski, et al.
Seminars in Thrombosis and Hemostasis|November 1, 2012
Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)Sony Jacob, Brianne L Dunn, Zaina P Qureshi, et al.
Cancer|January 5, 2022
TrueNTH Sexual Recovery Intervention for couples coping with prostate cancer: Randomized controlled trial resultsDaniela Wittmann, Akanksha Mehta, Sharon L Bober, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 27, 2022
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitorsSteven W Pipe, Cédric Hermans, Meera Chitlur, et al.
Pageof 127